Abstract: The present application is at least directed to a system including a processor and non-transitory memory including computer-executable instructions, which when executed by the processor, perform receiving, via a user operating the system, a selection of a mode for recognizing objects. The processor is also configured to execute the instructions of causing a camera operably coupled to the system to operate in the selected mode for recognizing objects. The processor is further configured to execute the instructions of receiving, via the user operating the system, an image of a selected object. The processor is even further configured to execute the instructions of evaluating, via a trained machine learning model, one or more attributes of the selected object. The processor is yet further configured to execute the instructions of generating an image description based on at least a subset of the evaluated one or more attributes.

Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.

Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.

Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.

Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.

Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.

Abstract: The free-space gesture MIDI controller technique described herein marries the technologies embodied in a free-space gesture controller with MIDI controller technology, allowing a user to control an infinite variety of electronic musical instruments through body gesture and pose. One embodiment of the free-space gesture MIDI controller technique described herein uses a human body gesture recognition capability of a free-space gesture control system and translates human gestures into musical actions. Rather than directly connecting a specific musical instrument to the free-space gesture controller, the technique generalizes its capability and instead outputs standard MIDI signals, thereby allowing the free-space gesture control system to control any MIDI-capable instrument.

Abstract: The present disclosure relates to methods for assessing increased risk of preeclampsia in a pregnant woman. The methods described herein employ measuring relaxin levels, and optionally measuring C-reactive protein levels in a biological sample of a pregnant woman. The disclosure further encompasses methods of reducing risk of preeclampsia through administration of a pharmaceutical formulation of relaxin to a pregnant woman.

Abstract: The present disclosure relates to methods for detecting an increased risk of preeclampsia, determining the presence of preeclampsia, reducing the likelihood that preeclampsia will develop and treating preeclampsia. It also provides methods of measuring relaxin levels in a biological sample of a pregnant woman.

Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.

Abstract: Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use.

Abstract: The present disclosure relates to methods for assessing increased risk of preeclampsia in a pregnant woman. The methods described herein employ measuring relaxin levels, and optionally measuring C-reactive protein levels in a biological sample of a pregnant woman. The disclosure further encompasses methods of reducing the risk of preeclampsia and treating it, once it has occurred by administering a pharmaceutical formulation of relaxin to a pregnant woman.

Abstract: Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use.

Abstract: The free-space gesture MIDI controller technique described herein marries the technologies embodied in a free-space gesture controller with MIDI controller technology, allowing a user to control an infinite variety of electronic musical instruments through body gesture and pose. One embodiment of the free-space gesture MIDI controller technique described herein uses a human body gesture recognition capability of a free-space gesture control system and translates human gestures into musical actions. Rather than directly connecting a specific musical instrument to the free-space gesture controller, the technique generalizes its capability and instead outputs standard MIDI signals, thereby allowing the free-space gesture control system to control any MIDI-capable instrument.

Abstract: Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use.

Abstract: The present disclosure relates to methods for detecting an increased risk of preeclampsia, determining the presence of preeclampsia, reducing the likelihood that preeclampsia will develop and treating preeclampsia. It also provides methods of measuring relaxin levels in a biological sample of a pregnant woman.

Abstract: Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use.

Abstract: The Universal Plug and Play architecture contemplates devices and control points that can automatically integrate themselves into a network and provide functionality to a user. Extensions are provided that allow an information presentation appliance to identify categories of information the user wishes that appliance to display. The appliance, acting as a device, can advertise functionality that only allows for the display of information that matches the categories selected by the user. Alternatively, the appliance can act as a control point and request information from information storage devices that matches the categories selected by the user. Using either alternative, the user is allowed to tune, at the appliance, the information that the appliance presents.

Abstract: Orthodontic methods comprise applying force to reposition teeth and administering a tissue remodeling and/or an angiogenic substance(s) to the periodontal tissue surrounding the teeth to be moved. The substance(s) may be delivered before, during, or after the teeth are moved, and the substance(s) may be selectively applied only to those teeth undergoing movement at any particular time. The substance(s) may be applied from the dental repositioning appliance or may be applied separately, either topically or by injection.

Abstract: The invention relates to the discovery that relaxin receptors exist in bone and related sutures. As such, bone can be remodeled, repaired, removed or grown. Particularly, the invention pertains to a method for modifying a target bone by administering a relaxin compound which binds to relaxin receptors and by monitoring a change in the target bone. The invention further encompasses methods of modifying the height of a human subject.